A new cell-penetrating peptide derived from Arabidopsis achieved over 99% cell entry at just 2 μM, dramatically outperforming standard CPPs like Tat-PTD and MTS.
>99% vs <10% penetrationAra-27 achieved near-complete cell entry at 2 μM while standard CPPs Tat-PTD and MTS showed minimal uptake
What the researchers found
Ara-27 achieved >99% cell-penetrating efficiency at 2 μM in human cells compared to <10% for Tat-PTD and MTS, with 8-22x higher intracellular fluorescence intensity.
Why it matters
Getting drugs and molecules inside cells is a major challenge in medicine. A CPP that works at low concentrations with near-complete efficiency could transform drug delivery for gene therapies, siRNA, and small molecules.
The numbers in context
>99% penetration at 2 uM (Ara-27) vs <10% (TAT, MTS); 8-22x fluorescence intensity; internalized at 0.2 uM; no cytotoxicity
How the study worked
In-vitro comparison study using flow cytometry and confocal microscopy to measure FITC-labeled peptide uptake in human dermal fibroblasts and dental pulp stem cells.
Who was studied
Human dermal fibroblasts (HDF) and human dental pulp stem cells (hDPSC) treated with Ara-27, TAT-PTD, and MTS
What this study cannot tell us
In-vitro study only with two human cell types; no in-vivo testing; cargo delivery efficiency not tested; mechanism of enhanced uptake not fully characterized.
How to read the evidence
Strong in-vitro evidence with quantitative comparisons across two cell types, but lacks in-vivo validation and cargo delivery testing.
When this study was published
Published in 2020; Ara-27 is a relatively new CPP and follow-up in-vivo studies would strengthen its therapeutic potential.
The bigger picture
This represents a significant advance in peptide-based drug delivery technology, potentially enabling more efficient intracellular delivery of therapeutics that currently cannot cross cell membranes effectively.
Questions still open
- Does Ara-27 maintain its superior penetration when carrying therapeutic cargo like siRNA or drugs?
- How does Ara-27 perform in vivo — does it show tissue-specific uptake or broad biodistribution?
- What is the mechanism behind Ara-27 dramatically superior cell entry compared to Tat-PTD?
Common questions
What makes Ara-27 better than other cell-penetrating peptides?
Where does Ara-27 come from?
Read the original research
Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides.
Biotechnology progress, 36(5), e3014
Citation
Min, Sol; Kim, Kichul; Ku, Seockmo; Park, Jeong-Yoon; Seo, Jeongmin; Roh, Sangho. (2020). Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides.. Biotechnology progress, 36(5), e3014. https://doi.org/10.1002/btpr.3014